Lung Cancer Clinical Trials in Cincinnati, OH

Lung Cancer Clinical Trials in Cincinnati, OH

View the best 10 lung cancer medical studies in Cincinnati, Ohio. Access promising new therapies by applying to a Cincinnati-based Lung Cancer clinical trial.

Trials in Cincinnati, Ohio

Here are the top 10 medical studies for lung cancer in Cincinnati, Ohio

Image of Research Site in Chandler, United States.

Durvalumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing a new cancer treatment (durvalumab with SoC SBRT) against the current best treatment (placebo with SoC SBRT) for early stage non-small cell lung cancer.
Image of University of California at Davis in Davis, United States.

ONC-392 +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Image of University of Texas Southwestern Medical Center in Dallas, United States.

TVB-2640

Fatty Acid Synthase Inhibitor

Recruiting1 awardPhase 2
This trial will test a new cancer drug, TVB-2640, on patients with a specific type of non-small cell lung cancer.
Image of Providence Cancer Institute Franz Clinic in Portland, United States.

FF-10832 +1 More

Anti-metabolites

Recruiting3 awardsPhase 2
This trial is testing a new cancer drug, given in combination with another drug that is already used to treat cancer.
Image of Children's Hospital of Alabama in Birmingham, United States.

Thoracotomy +1 More

Procedure

Recruiting2 awardsPhase 3
This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.
Image of Grady Health System in Atlanta, United States.

Durvalumab +2 More

PD-L1 Inhibitor

Recruiting1 awardPhase 1
This trial is testing two different radiation schedules with durvalumab to see which is better at treating NSCLC.
Image of Alabama Oncology - Grandview in Birmingham, United States.

Sitravatinib +2 More

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial will compare the effectiveness of sitravatinib when given with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression after platinum-based chemotherapy and checkpoint inhibitor therapy.
Image of Washington University School of Medicine - Siteman Cancer Center in Saint Louis, United States.

Quaratusugene Ozeplasmid

Virus Therapy

Recruiting1 awardPhase 1 & 2
This trial will test using a combination of quaratusugene ozeplasmid and atezolizumab as ongoing treatment for patients with Extensive Stage Small Cell Lung Cancer. The trial
Image of Sutter Auburn Faith Hospital in Auburn, United States.

Pembrolizumab +2 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial compares ramucirumab+pembrolizumab vs chemo for non-small cell lung cancer. Ramucirumab+pembrolizumab may stop tumors from growing and spreading, while chemo kills/stops cells from dividing/spreading. Results may help find out if this combo is more effective than chemo.
Image of Research Site in La Jolla, United States.

Durvalumab +5 More

Checkpoint Inhibitor

Recruiting2 awardsPhase 3
This trial tests if two drugs plus chemo work better than one drug plus chemo to treat metastatic lung cancer with gene mutations.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.